210 results on '"Mason, Emily F"'
Search Results
2. Hematopoietic Neoplasms of the Sinonasal Tract
3. PD-1H/VISTA mediates immune evasion in acute myeloid leukemia
4. LAIR-1 agonism as a therapy for acute myeloid leukemia
5. Fine Needle Aspiration of CD20‐Negative Diffuse Large B Cell Lymphoma Presenting as an Anterior Neck Mass.
6. Thrombotic Microangiopathy Due to Progressive Disseminated Histoplasmosis in a Child With Down Syndrome and Acute Lymphoblastic Leukemia
7. Clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology Group
8. Cell-programmed nutrient partitioning in the tumour microenvironment
9. Multiparametric in situ imaging of NPM1-mutated acute myeloid leukemia reveals prognostically-relevant features of the marrow microenvironment
10. PD-1H/VISTA mediates immune evasion in acute myeloid leukemia
11. TP53 Mutations Are Associated with Increased Infections and Reduced Hematopoietic Cell Transplantation Rates in Myelodysplastic Syndrome and Acute Myeloid Leukemia
12. Blast phenotype and comutations in acute myeloid leukemia with mutated NPM1 influence disease biology and outcome
13. Distinct bone marrow findings associated with a noncanonical UBA1 variant in VEXAS syndrome.
14. Exploiting Tumor Necrosis Factor Aberrations in Marginal Zone Lymphoma
15. Diagnostic Utility of CD200 Immunohistochemistry in Distinguishing EBV-Positive Large B-Cell Lymphoma From Classic Hodgkin Lymphoma
16. Supplementary File 1 from PI3K Inhibition Restores and Amplifies Response to Ruxolitinib in Patients with Myelofibrosis
17. Data from PI3K Inhibition Restores and Amplifies Response to Ruxolitinib in Patients with Myelofibrosis
18. PI3K Inhibition Restores and Amplifies Response to Ruxolitinib in patients with Myelofibrosis
19. Supplementary Figures 1-9 from Aerobic Glycolysis Suppresses p53 Activity to Provide Selective Protection from Apoptosis upon Loss of Growth Signals or Inhibition of BCR-Abl
20. Data from Aerobic Glycolysis Suppresses p53 Activity to Provide Selective Protection from Apoptosis upon Loss of Growth Signals or Inhibition of BCR-Abl
21. Supplementary Figure Legends 1-9 from Aerobic Glycolysis Suppresses p53 Activity to Provide Selective Protection from Apoptosis upon Loss of Growth Signals or Inhibition of BCR-Abl
22. GVHD like skin eruption post-autologous stem cell transplantation
23. Contributing Authors
24. Programmed Death-1 Homolog (PD-1H/VISTA) Blockade Confers a Synergistic Anti-Leukemia Effect with PD-1 Blockade
25. Extranodal Marginal Zone Lymphomas Show Recurrent Mutations in DNA Repair Genes, Cancer-Associated Proliferative Signaling and NOTCH1 Signaling Pathways, Regardless of Anatomic Site
26. TP53 Mutations Are Associated with Increased Infections and Reduced Hematopoietic Cell Transplantation Rates in Myelodysplastic Syndrome and Acute Myeloid Leukemia
27. Secondary‐type mutations do not impact prognosis in acute myelogenous leukemia AML with mutated NPM1
28. Thrombotic Microangiopathy Due to Progressive Disseminated Histoplasmosis in a Child With Down Syndrome and Acute Lymphoblastic Leukemia
29. COVID monoclonal antibody therapy detected by serum immunofixation electrophoresis
30. Succinate dehydrogenase deficiency is associated with decreased 5-hydroxymethylcytosine production in gastrointestinal stromal tumors: implications for mechanisms of tumorigenesis
31. Myeloid sarcoma with NPM1 mutation may be clinically and genetically distinct from AML with NPM1 mutation: a study from the Bone Marrow Pathology Group.
32. Oligoclonal Gamma‐delta T cell expansion in response to Ehrlichia infection
33. Impact of Molecular Features of Diffuse Large B-Cell Lymphoma on Treatment Outcomes with Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy
34. Chronic myeloid leukemia with pure erythroid leukemia blast crisis
35. Update on Pediatric and Young Adult Mature Lymphomas
36. A novel differentiation response with combination IDH inhibitor and intensive induction therapy for AML
37. Pediatric hematolymphoid pathology in the gastrointestinal tract
38. Malaise, Weight Loss, and Acute Kidney Injury in a 13-year-old Girl
39. Isocitrate dehydrogenase inhibitor‐driven differentiation may resemble secondary graft failure in post‐allogeneic haematopoietic cell transplantation relapsed acute myeloid leukaemia
40. Unraveling the Transcriptional Landscape of Nodular Lymphocyte-Predominant Hodgkin Lymphoma and T-Cell/Histiocyte Rich Large B-Cell Lymphoma: Impact of Tumor Microenvironment and Checkpoint Gene Expression
41. Oncofetal Protein SALL4 Is Highly Expressed in Myelodysplastic Syndrome Alongside with NAT10 and P53
42. Durable Long-Term Response in a Patient With Diffuse Large B-Cell Lymphoma Treated With Nivolumab
43. Primary central nervous system erythroid sarcoma with NFIA‐CBFA2T3 translocation: A rare but distinct clinicopathologic entity
44. Chronic myeloid leukemia with pure erythroid leukemia blast crisis.
45. Whole Exome and Transcriptome Sequencing in 1042 Cases Reveals Distinct Clinically Relevant Genetic Subgroups of Follicular Lymphoma
46. Combination of Nivolumab, Lenalidomide and Rituximab in Relapsed/Refractory Non-Germinal Center Diffuse Large B Cell Lymphoma: Results from a Dose-Escalation Cohort
47. Bone Marrow Morphologic Findings in Patients Receiving IDH Inhibitor Therapy in Combination with Intensive Induction Chemotherapy: Challenges with Interpretation of the Day 14 Bone Marrow Biopsy
48. Myelodysplastic/myeloproliferative neoplasm with eosinophilia as a manifestation of Li Fraumeni Syndrome
49. Clinicopathologic and genetic characterization of nonacute NPM1-mutated myeloid neoplasms
50. 52. A rare (7;12) translocation resulting in a rearrangement of the IKZF1 locus with concurrent deletion of CDKN2A, CDKN2B and PAX5 loci: an unannotated genetic abnormality in pediatric B-lymphoblastic leukemia/lymphoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.